PHIBRO ANIMAL HEALTH CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $82.7m $64.6m $64.9m $54.7m $33.6m $54.4m $49.2m $32.6m $2.4m $48.3m
Depreciation, Depletion and Amortization $23.5m $26.0m $26.9m $27.6m $32.3m $31.9m $32.7m $34.0m $36.2m $45.6m $50.6m
Depreciation $17.7m $19.9m $21.0m $21.4m $23.2m $23.2m $23.8m $24.3m $26.5m $37.8m $43.7m
Amortization of Debt Issuance Costs $590k $727k $1.0m $2.0m
Amortization of Debt Issuance Costs and Discounts $989k $1.0m $883k $882k $882k $833k
Amortization of Intangible Assets $5.6m $6.0m $5.9m $6.1m $8.9m $8.7m $8.9m $9.7m $9.7m $7.8m
Capitalized Computer Software, Amortization $1.5m $1.2m $1.0m $1.3m $1.0m $1.5m $1.4m $1.4m
Amortization Cash Flow $8.9m $9.7m $9.7m $7.8m
Amortization Of Intangibles $8.9m $9.7m $9.7m $7.8m $6.8m
Depreciation Amortization Depletion $32.7m $34.0m $36.2m $45.6m $50.6m
Deferred Income Tax Expense (Benefit) ($22.2m) ($28k) $6.4m ($105k) $8.1m ($2.2m) ($803k) ($2.9m) ($12.0m) ($4.8m) $18.0m
Deferred Income Tax ($806k) ($2.8m) ($7.8m) ($4.9m) $18.0m
Deferred Tax ($806k) ($2.8m) ($7.8m) ($4.9m) $18.0m
Share-based Payment Arrangement, Noncash Expense $2.3m $2.3m $1.1m $475k $717k $1.4m
Impairment of Intangible Assets, Finite-lived $885.0m
Asset Impairment Charge $0 $0 $5.3m $0
Changes in operating assets and liabilities:
Change In Working Capital ($44.6m) ($41.1m) $33.1m ($21.6m) ($99.6m)
Increase (Decrease) in Accounts Receivable $13.1m $2.8m $11.9m $23.7m ($28.7m) $18.2m $23.6m ($5.3m) $8.7m $55.2m ($17.0m)
Change In Receivables ($23.6m) $5.3m ($8.7m) ($55.2m) ($17.0m)
Changes In Account Receivables ($23.6m) $5.3m ($8.7m) ($55.2m) ($17.0m)
Increase (Decrease) in Inventories $16.4m ($5.4m) $24.3m $21.0m $12.9m $12.5m $47.0m $11.2m ($2.6m) $44.3m ($98.7m)
Change In Inventory ($47.0m) ($11.2m) $2.6m ($44.3m) ($98.7m)
Increase (Decrease) in Accounts Payable ($3.2m) ($3.1m) $2.4m $12.1m ($7.7m) $3.2m $26.4m ($22.8m) $12.0m $45.6m ($4.2m)
Change In Payables And Accrued Expense $29.5m ($28.6m) $24.2m $92.7m ($4.2m)
Change In Accrued Expense $3.2m ($5.7m) $12.2m $47.2m $23.8m
Change In Other Current Assets ($3.5m) ($6.7m) $15.0m ($14.8m) ($3.5m)
Net Cash Provided by (Used in) Operating Activities $37.2m
$98.4m +164.35%
$70.0m -28.84%
$47.2m -32.62%
$59.3m +25.82%
$48.3m -18.61%
$31.6m -34.48%
$13.3m -57.94%
$87.6m +558.11%
$80.1m -8.53%
$66.1m -17.46%
Cash flows from investing activities:
Capital Expenditure $36.4m $20.9m $18.5m $29.9m $34.0m $29.3m ($37.0m) ($51.8m) ($41.2m) ($38.3m) ($53.4m)
Cash, Cash Equivalents, and Short-term Investments $91.6m
Payments to Acquire Businesses, Net of Cash Acquired $3.3m $286.5m $5.3m
Payments for (Proceeds from) Other Investing Activities ($137k) $1.1m $1.1m $404k $796k $1.3m ($620k) ($776k) ($326k) ($1.1m)
Net Other Investing Changes $620k $776k $326k $1.1m ($1.5m)
Net Cash Provided by (Used in) Investing Activities ($84.6m) ($14.1m) ($120.4m) ($18.6m) ($22.6m) ($74.0m) ($48.2m) ($288.7m) ($62.0m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($2.6m) $0
Proceeds from Issuance of Long-term Debt $250.0m $274.0m
Issuance Of Debt $297.0m $326.0m $276.0m $1.2b $274.0m
Long Term Debt Issuance $297.0m $326.0m $276.0m $1.2b $274.0m
Long Term Debt Payments ($256.4m) ($283.3m) ($263.3m) ($946.0m) ($267.2m)
Net Issuance Payments Of Debt $40.6m $42.7m $12.7m $236.0m $6.8m
Net Long Term Debt Issuance $40.6m $42.7m $12.7m $236.0m $6.8m
Repayment Of Debt ($256.4m) ($283.3m) ($263.3m) ($946.0m) ($267.2m)
Payments of Ordinary Dividends, Common Stock $16 $16 $16 $19 $19 $19 $19 $19 $19 $19 ($19.5m)
Proceeds from Issuance of Common Stock $4.0m $5.5m $5.7m $1.1m $793k
Common Stock Dividend Paid ($19.4m) ($19.4m) ($19.4m) ($19.4m) ($19.5m)
Cash Dividends Paid ($19.4m) ($19.4m) ($19.4m) ($19.4m) ($19.5m)
Net Other Financing Charges ($4.8m) $3.7m ($31k) ($9.4m) ($2k)
Net Cash Provided by (Used in) Financing Activities ($11.8m)
($4.1m) +65.12%
$40.9m +1096.74%
($17.0m) -141.52%
$16.3m +196.16%
$27.0m +65.13%
($6.8m) -125.08%
$207.1m +3160.49%
($12.7m) -106.14%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($21.2m) $13.9m $24.0m ($33.0m) $29.3m ($2.6m) $51.7m
Beginning Cash Position $50.2m $74.2m $41.3m $70.6m $60.4m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $74.2m $41.3m $70.6m $68.0m $51.7m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($1.4m) $754k ($3.3m) ($1.1m) $3.2m
Effect Of Exchange Rate Changes ($1.4m) $754k ($3.3m) ($1.1m) $3.2m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $11.2m $12.2m $11.6m $10.8m $11.2m $14.6m $17.3m $32.1m
Income Taxes Paid, Net $16.8m $14.8m $15.2m $16.2m $20.9m $19.4m $17.9m $20.4m $15.4m $13.4m
Additional Financial Items
Accretion Expense $1.5m $1.4m $1.1m $0
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement ($1.7m) $0 $0 ($10.7m)
Foreign Currency Transaction Gain (Loss), before Tax $7.6m $113k $1.1m $55k ($826k) $4.5m $5.2m ($2.5m) ($23.9m) ($7.9m)
Foreign Currency Transaction Gain (Loss), Unrealized $7.7m $867k $635k $1.9m $2.5m $9.7m $4.8m $10.4m ($13.1m) ($600k)
Gain (Loss) Related to Litigation Settlement $899k $2.9m
General and Administrative Expense $38.5m
Goodwill $21.1m $24.0m $27.3m $27.3m $52.7m $52.7m $53.2m $53.3m $54.6m $59.6m $0
Income Tax Expense (Benefit) ($6.0m) $15.9m $23.2m $16.8m $22.0m $12.1m $23.2m $21.5m $8.5m $19.7m
Interest Expense Nonoperating $23.0m $37.2m
Pension Cost (Reversal of Cost) $4.4m $1.9m
Pension Expense (Reversal of Expense), Noncash $1.7m $0 $0 $10.7m
Revenue from Contract with Customer, Including Assessed Tax $828.0m
Cash Flow From Continuing Financing Activities $16.3m $27.0m ($6.8m) $207.1m ($12.7m)
Cash Flow From Continuing Investing Activities ($22.6m) ($74.0m) ($48.2m) ($288.7m) ($62.0m)
Change In Account Payable $26.4m ($22.8m) $12.0m $45.6m ($4.2m)
Change In Cash Supplemental As Reported $24.0m ($33.0m) $29.3m ($2.6m)
Change In Payable $26.4m ($22.8m) $12.0m $45.6m ($4.2m)
Changes In Cash $25.4m ($33.7m) $32.6m ($1.4m) ($8.6m)
End Cash Position $74.2m $41.3m $70.6m $68.0m $51.7m
Financing Cash Flow $16.3m
$27.0m +65.13%
($6.8m) -125.08%
$207.1m +3160.49%
($12.7m) -106.14%
Free Cash Flow ($5.4m) ($38.5m) $46.4m $41.8m $12.8m
Investing Cash Flow ($22.6m) ($74.0m) ($48.2m) ($288.7m) ($62.0m)
Net Business Purchase And Sale ($13.5m) $0 ($3.3m) ($286.5m) $5.3m
Net Foreign Currency Exchange Gain Loss ($4.8m) ($10.4m) $13.1m $600k ($4.2m)
Net Investment Purchase And Sale $27.4m ($23.0m) ($4.0m) $35.0m ($12.5m)
Operating Gains Losses ($6.0m) ($10.4m) $23.8m $600k ($4.2m)
Other Non Cash Items $1.2m $1.1m ($537k) $6.1m
Pension And Employee Benefit Expense $0 $0 $10.7m $0 $0
Purchase Of Business ($13.5m) $0 ($3.3m) ($286.5m) $5.3m
Purchase Of Investment ($64.1m) ($40.0m) ($65.5m) ($14.0m) ($41.0m)
Sale Of Investment $91.5m $17.0m $61.5m $49.0m $28.5m
Stock Based Compensation $0 $0 $475k $717k $1.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.